Storm Bratchett Memorial Blood Drive March 3-4
Hoxworth Blood Center has announced the 13th Annual Storm Bratchett Memorial Blood Drive, scheduled for 11 a.m.-7 p.m., Thursday, March 3, and 11 a.m.-6 p.m., Friday, March 4, at Christ’s Community Church, located at 2433 25th St. in Portsmouth.
This event is the 13th memorial drive for Storm Bratchett, who was only 17 years old when accidentally shot in the chest with an arrow in 2008. He was rushed to the Southern Ohio Medical Center where doctors worked for hours to save his life, using more than 40 pints of blood. He did not survive.
“While Storm’s life was tragically cut short, his legacy lives on through this annual blood drive,” said Alecia Lipton, Hoxworth spokesperson. “We hope that the community will honor Storm’s selfless, giving spirit by making a lifesaving blood donation in his memory.”
Appointments for this drive are strongly encouraged, but walk-ins are welcome. Schedule an appointment by calling 513-451-0910 or visit www.hoxworth.org/groups/storm.
About Hoxworth:
Hoxworth Blood Center, University of Cincinnati, was founded in 1938, and serves more than 30 hospitals in 18 counties in Southwestern Ohio, Northern Kentucky and Southeastern Indiana. Annually, Hoxworth collects more than 100,000 units of blood from local donors to help save the lives of patients in area hospitals. Hoxworth Blood Center: Saving Lives Close to Home. Replace with your text
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.
Combination immunotherapy helps overcome melanoma treatment resistance
November 10, 2025
MSN highlighted research led by the University of Cincinnati Cancer Center's Trisha Wise-Draper showing a combination of immunotherapy medications can activate a robust immune response and help overcome treatment resistance in patients with refractory melanoma.